Xencor, Inc Equity Securities FVNINoncurrent
Xencor, Inc (XNCR) had Equity Securities FVNINoncurrent of $0 as of 2024-12-31, per its 10-K filed 2025-02-27.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent › Long-Term Investments
us-gaap:EquitySecuritiesFVNINoncurrent · last filed 2025-02-27
- 2024-12-31: Equity Securities FVNINoncurrent $0.00.
- 2024-09-30: Equity Securities FVNINoncurrent $0.00.
- 2024-06-30: Equity Securities FVNINoncurrent $43.78M.
- 2024-03-31: Equity Securities FVNINoncurrent $43.56M.
| Period end | Equity Securities FVNINoncurrent |
|---|---|
| 2024-12-31 | $0.00 10-K · filed 2025-02-27 |
| 2024-09-30 | $0.00 10-Q/A · filed 2025-02-24 |
| 2024-06-30 | $43.78M 10-Q/A · filed 2025-02-24 |
| 2024-03-31 | $43.56M 10-Q/A · filed 2025-02-24 |
| 2023-12-31 | $64.21M 10-K · filed 2025-02-27 |
| 2023-09-30 | $64.21M 10-Q · filed 2023-11-08 |
| 2023-06-30 | $64.21M 10-Q · filed 2023-08-03 |
| 2023-03-31 | $54.21M 10-Q · filed 2023-05-08 |
| 2022-12-31 | $54.38M 10-K/A · filed 2025-02-24 |
| 2022-09-30 | $31.12M 10-Q · filed 2022-11-07 |
| 2022-06-30 | $31.12M 10-Q · filed 2022-08-03 |
| 2022-03-31 | $31.26M 10-Q · filed 2022-05-05 |
| 2021-12-31 | $31.26M 10-K · filed 2023-02-27 |
| 2021-09-30 | $16.58M 10-Q · filed 2021-11-08 |
| 2020-12-31 | $16.07M 10-K · filed 2022-02-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Septerna, Inc. (SEPN) | United States | $1.783B | -63.01 |
| ANI PHARMACEUTICALS INC (ANIP) | United States | $1.810B | 18.77 |
| COMPASS Pathways plc (CMPS) | $1.812B | -4.87 | |
| Eton Pharmaceuticals, Inc. (ETON) | United States | $1.701B | 80.74 |
| Zymeworks Inc. (ZYME) | United States | $1.902B | -12.44 |
| Xeris Biopharma Holdings, Inc. (XERS) | United States | $1.632B | -80.10 |
| Stoke Therapeutics, Inc. (STOK) | United States | $1.630B | -9.82 |
| Rapport Therapeutics, Inc. (RAPP) | United States | $1.623B | -14.56 |
| Sarepta Therapeutics, Inc. (SRPT) | United States | $1.941B | -13.89 |
| Syndax Pharmaceuticals Inc (SNDX) | United States | $1.606B | -8.82 |